|
Axial spondyloarthritis
|
0.100 |
Biomarker
|
disease |
BEFREE |
• Maintaining stable dose of TNF-α inhibitor for long-term in axSpA may be relatively safe for managing atherogenic lipid.
|
31486930 |
2020 |
|
Degenerative polyarthritis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
β4GalT1 promoted cell invasion, MMP-3 production, and the secretion of TNF-α, IL-1β, and IL-6. si-TNF-α attenuated the β4GalT1-enhanced cell invasion and inflammatory factor secretion in OA-FLS.
|
31210280 |
2019 |
|
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
β4GalT1 promoted cell invasion, MMP-3 production, and the secretion of TNF-α, IL-1β, and IL-6. si-TNF-α attenuated the β4GalT1-enhanced cell invasion and inflammatory factor secretion in OA-FLS.
|
31210280 |
2019 |
|
Adult Diffuse Large B-Cell Lymphoma
|
0.070 |
Biomarker
|
disease |
BEFREE |
β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma.
|
31731887 |
2020 |
|
Periodontal Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
β-glucan reduced plasmatic levels of TNF-α in diabetic animals with PD and of IL-10 in animals with PD (<i>p</i> < 0.05).
|
28906456 |
2017 |
|
Portal hypertensive gastropathy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
β-arr1 limited the activation of p65 to repress TNF-α-induced inducible nitric oxide synthase (iNOS) expression and NO release, which could regulate ER stress/PUMA-mediated mucosal apoptosis in PHG.
|
26119788 |
2015 |
|
Metabolic Syndrome X
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
α<sub>1</sub>-adrenoceptor blockade, endothelial protection, TNF-α suppressing and antioxidant activity together with favorable pharmacokinetic parameters determines high efficacy of MH-76, leading to the effective improvement of hemodynamic and metabolic disturbances in metabolic syndrome.
|
31133498 |
2019 |
|
Sepsis
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
[The postburn changes of the plasma levels of PGE2 and TNF alpha in burn patients].
|
11774822 |
2001 |
|
Heart failure
|
0.600 |
AlteredExpression
|
disease |
LHGDN |
[The effects of exercise training on plasma tumor necrosis factor-alpha, blood leucocyte and its components in congestive heart failure patients].
|
12133434 |
2002 |
|
Toxic Shock Syndrome
|
0.540 |
Biomarker
|
disease |
RGD |
[The effect of transmembrane- and secreted-tumor necrosis factor-alpha on shock liver].
|
12622907 |
2002 |
|
Hepatorenal Syndrome
|
0.200 |
Biomarker
|
disease |
RGD |
[Study on the expressions and roles of renal heat shock protein 72 and Toll-like receptor 4 in hepatorenal syndrome in rat].
|
18093430 |
2007 |
|
Lung diseases
|
0.600 |
Biomarker
|
group |
RGD |
[Studies on the expression of mRNA of anti- and pro-inflammatory cytokines in acute lung injury induced by lipopolysaccharide in rat].
|
15461830 |
2004 |
|
Gastritis
|
0.300 |
Therapeutic
|
disease |
RGD |
[Serumimmunological study of moxibustion on helicobacter pylori gastritis in rats].
|
25335260 |
2014 |
|
Rheumatoid Arthritis
|
0.700 |
Biomarker
|
disease |
LHGDN |
[Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
|
14979058 |
2003 |
|
Silicosis
|
0.300 |
Therapeutic
|
disease |
RGD |
[Regulation of ursolic acid on TNF-alpha and collagen in silicotic rats].
|
25199287 |
2014 |
|
Insulin Resistance
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
[Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics].
|
16493877 |
2005 |
|
Insulin Sensitivity
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics].
|
16493877 |
2005 |
|
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
[Polymorphisms of tumor necrosis factor genes in sporadic and hereditary breast cancer].
|
18416134 |
2007 |
|
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
[Polymorphism of the tumor necrosis factor alpha gene in patients with infiltrative tuberculosis and from the Bashkorstan populations].
|
12391840 |
2002 |
|
Hepatopulmonary Syndrome
|
0.200 |
Therapeutic
|
disease |
RGD |
[Molecular mechanism of tumor necrosis factor-alpha monoclonal antibody in hepatopulmonary syndrome in rats].
|
26236934 |
2015 |
|
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
LHGDN |
[Expression of tumor necrosis factor-alpha and nuclear factor-kappa B in childhood ulcerative colitis].
|
14731353 |
2003 |
|
Intervertebral Disk Displacement
|
0.210 |
Biomarker
|
disease |
RGD |
[Effects of sacral canal injection on nerve root local inflammatory factors in rat model with lumbar disc herniation].
|
24826482 |
2014 |
|
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
|
0.200 |
Therapeutic
|
disease |
RGD |
[Effect of electroacupuncture stimulation of back-shu points on expression of TNF-alpha and lipid peroxidation reaction in the liver tissue in non-alcoholic fatty liver disease rats].
|
25219124 |
2014 |
|
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
|
0.200 |
Therapeutic
|
phenotype |
RGD |
[Effect of electroacupuncture stimulation of back-shu points on expression of TNF-alpha and lipid peroxidation reaction in the liver tissue in non-alcoholic fatty liver disease rats].
|
25219124 |
2014 |
|
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
|
0.200 |
Therapeutic
|
phenotype |
RGD |
[Effect of electroacupuncture stimulation of back-shu points on expression of TNF-alpha and lipid peroxidation reaction in the liver tissue in non-alcoholic fatty liver disease rats].
|
25219124 |
2014 |